FDA Approved: OXAPROZIN — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

FDA approved a supplemental application for Oxaprozin filed by Chartwell RX, LLC., updating an existing approved generic oxaprozin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Oxaprozin (Oxaprozin)

Snippet

SUPPL AP for OXAPROZIN (OXAPROZIN)